JWCA ADVISES INOTEK PHARMACEUTICALS ON ITS $52.0 million Convertible bond offering

August 2016 | read press release

Transaction Background

J. Wood Capital Advisors was hired by Inotek to manage its capital structure and raise new capital in an efficient way:

• Provided full analysis on Company’s previous Convertible and implications for a new issuance, including:

  • Issuer call features

  • Investor make-whole provisions

  • Execution fees
  • Public vs private marketing
• Designed the strategey and execution process to meet the Company's objectives:

  • Raised significant capital meet Company's operating needs on attractive terms

  • Optimized amount of private marketing to maximize capital raise within the constraints of limited float and borrow

• Assisted the team with documentation, accounting, and tax review

• Provided advice, support and analysis throughout the negotiation and deal preparation proces

RESULTS

The Company executed a successful capital raise:

• Net Cash to Balance Sheet of approximately $49mm provided Inotek with critical funding for ongoing development of trabodenoson as a monotherapy and as a fixed-dose combination with latanoprost for the reduction of intraocular pressure